Uterine fibroids are extremely common. By some estimates, up to 70 to 80 percent of women will develop at least one fibroid by age 50, though many will never know it. The gap between how many women have fibroids and how many are actually diagnosed is enormous, because the majority of fibroids cause no symptoms at all.
Diagnosed vs. Actual Prevalence
The numbers you see depend on how researchers look for fibroids. When doctors rely on clinical diagnoses alone, the rates appear modest. A large US population study published in the American Journal of Obstetrics & Gynecology found that about 9.6% of women in the study had a documented fibroid diagnosis in 2014. The proportion peaked at 15.9% among women aged 50 to 54.
But when researchers use ultrasound screening on women who have no symptoms, fibroids turn up far more often. A pilot study of asymptomatic women aged 18 to 30 found a 15% prevalence rate through ultrasound, even though none of these women had reported problems. That’s young, healthy women with no complaints. Among older women screened with imaging, prevalence climbs much higher. The widely cited figure of 70 to 80% by age 50 comes from studies that systematically screened tissue samples, revealing fibroids too small to cause symptoms or show up on a standard exam.
In other words, most fibroids are invisible to the women who have them. Only a fraction grow large enough or land in the right spot to cause heavy bleeding, pelvic pressure, or pain.
Who Gets Fibroids More Often
Race is the single strongest demographic factor. Black women are diagnosed at significantly higher rates than other groups. The same US population study found that 18.5% of Black women had a fibroid diagnosis, compared to lower rates across other racial and ethnic groups. Black women also tend to develop fibroids at younger ages, have more of them, and experience more severe symptoms.
Family history matters too. If your mother or sister had fibroids, your risk goes up, though researchers haven’t pinned down a single gene responsible. The condition likely involves multiple genetic pathways interacting with hormones and environment.
Body weight shows a more complicated relationship than you might expect. A prospective study from Henry Ford Health found that women with a BMI between 30 and 35 had a modestly higher rate of fibroid development compared to women with a BMI under 25. But the same study found that women with a BMI of 40 or above actually had a lower rate of new fibroids, a finding that surprised researchers and suggests the link between weight and fibroids isn’t straightforward.
How Age Changes the Picture
Fibroids are driven by estrogen and progesterone, the hormones that regulate your menstrual cycle. This means they follow a predictable life pattern: rare before puberty, increasingly common through the 30s and 40s, and peaking around age 50 to 54. After menopause, when hormone levels drop, most fibroids shrink on their own. As one Cleveland Clinic specialist put it, “When you stop your periods, the fibroids go to sleep.” For many women, symptoms that were bothersome in their 40s resolve entirely without treatment once menopause arrives.
This doesn’t mean fibroids disappear completely after menopause. They can persist as smaller, calcified masses. And women who take hormone replacement therapy may find their fibroids don’t shrink as expected, since the supplemental hormones can keep them active.
When Fibroids Cause Problems
Most fibroids are small and produce no symptoms. When they do cause trouble, the most common complaints are heavy or prolonged menstrual bleeding, pelvic pressure or pain, frequent urination (from a fibroid pressing on the bladder), and difficulty emptying the bladder. Some women also experience constipation, backache, or leg pain depending on where the fibroid sits.
The severity depends less on the number of fibroids and more on their size and location. A single fibroid growing into the uterine cavity can cause significant bleeding, while several fibroids embedded in the uterine wall might cause no symptoms at all. Fibroids range from the size of a seed to, in rare cases, the size of a grapefruit or larger.
Effects on Fertility and Pregnancy
Fibroids are associated with reduced fertility in about 5 to 10% of cases where a woman is having difficulty conceiving. But when researchers rule out every other possible cause of infertility, fibroids account for only 2 to 3% of cases on their own. So while they can contribute to fertility problems, they’re rarely the sole explanation.
During pregnancy, fibroids are detected in 0.1 to 3.9% of cases. Most pregnancies with fibroids proceed normally, but depending on size and placement, fibroids can occasionally contribute to complications like preterm delivery, abnormal fetal positioning, or the need for a cesarean section. If you’re planning a pregnancy and know you have fibroids, the location relative to the uterine cavity is the key detail your provider will assess.
The Broader Impact
Fibroids are not just a personal health issue. They carry a substantial economic burden. A Johns Hopkins analysis estimated the total annual cost of uterine fibroids in the United States at $41.4 billion in 2022 dollars (up from $34.4 billion in 2010), factoring in direct medical costs, lost productivity, and disability. When newer treatment costs and fibroid-related infertility care were included, the figure reached $42.2 billion. Much of this cost comes from surgical procedures, hospitalizations, and missed work days, a reflection of how many women live with symptoms for years before seeking or receiving treatment.
Despite being one of the most common conditions affecting women of reproductive age, fibroids remain under-researched relative to their prevalence. Many women aren’t told about their fibroids until they show up incidentally on imaging for something else, and the gap between symptom onset and diagnosis can stretch for years.